Sometimes, the largest and the stablest businesses are excellent options to anchor your portfolio with some steady cash flow. In particular, GlaxoSmithKline (NYSE: GSK) and Bristol-Myers Squibb (NYSE: BMY) are two of the world’s most preeminent pharmaceutical companies, but neither has consistently outperformed the market over the past five years.